China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanism study of aspartic acid regulating CCL5 to affect high-fat-driven macrophage polarization in the progression of atherosclerosis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135720
Registration Time: 2026/11/01
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348693
Published by HT Digital Content Services with permission from Health Daily Digest....